These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20661131)

  • 1. Activation of the MEK-S6 pathway in high-grade ovarian cancers.
    Ventura AP; Radhakrishnan S; Green A; Rajaram SK; Allen AN; O'Briant K; Schummer M; Karlan B; Urban N; Tewari M; Drescher C; Knudsen BS
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):499-508. PubMed ID: 20661131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor.
    Dumble M; Crouthamel MC; Zhang SY; Schaber M; Levy D; Robell K; Liu Q; Figueroa DJ; Minthorn EA; Seefeld MA; Rouse MB; Rabindran SK; Heerding DA; Kumar R
    PLoS One; 2014; 9(6):e100880. PubMed ID: 24978597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
    Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
    Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
    Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
    Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
    J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptically driven phosphorylation of ribosomal protein S6 is differentially regulated at active synapses versus dendrites and cell bodies by MAPK and PI3K/mTOR signaling pathways.
    Pirbhoy PS; Farris S; Steward O
    Learn Mem; 2017 Aug; 24(8):341-357. PubMed ID: 28716954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
    Ruicci KM; Pinto N; Khan MI; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC
    Oral Oncol; 2018 Sep; 84():95-103. PubMed ID: 30115483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer.
    Yarchoan M; Ma C; Troxel AB; Stopenski SJ; Tang W; Cohen AB; Pappas-Paxinos M; Johnson BA; Chen EY; Feldman MD; Brose MS
    Horm Cancer; 2016 Jun; 7(3):188-95. PubMed ID: 26994002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between PI3 kinase/PDK1/Akt/Rac1 and Ras/Raf/MEK/ERK pathways downstream PDGF receptor.
    Niba ET; Nagaya H; Kanno T; Tsuchiya A; Gotoh A; Tabata C; Kuribayashi K; Nakano T; Nishizaki T
    Cell Physiol Biochem; 2013; 31(6):905-13. PubMed ID: 23817184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer.
    Yuge K; Kikuchi E; Hagiwara M; Yasumizu Y; Tanaka N; Kosaka T; Miyajima A; Oya M
    Mol Cancer Ther; 2015 Sep; 14(9):2112-20. PubMed ID: 26184482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
    Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
    Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
    Jang K; Kim M; Seo HS; Shin I
    Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling.
    Halilovic E; She QB; Ye Q; Pagliarini R; Sellers WR; Solit DB; Rosen N
    Cancer Res; 2010 Sep; 70(17):6804-14. PubMed ID: 20699365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt activation by Ca
    Gocher AM; Azabdaftari G; Euscher LM; Dai S; Karacosta LG; Franke TF; Edelman AM
    J Biol Chem; 2017 Aug; 292(34):14188-14204. PubMed ID: 28634229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
    Chen C; Chang YC; Lan MS; Breslin M
    Int J Oncol; 2013 Mar; 42(3):1113-9. PubMed ID: 23354006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
    Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells.
    Hirashita Y; Tsukamoto Y; Yanagihara K; Fumoto S; Hijiya N; Nakada C; Uchida T; Matsuura K; Kodama M; Okimoto T; Daa T; Seike M; Iha H; Shirao K; Murakami K; Moriyama M
    Cancer Sci; 2016 Dec; 107(12):1919-1928. PubMed ID: 27699948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific.
    Baudhuin LM; Cristina KL; Lu J; Xu Y
    Mol Pharmacol; 2002 Sep; 62(3):660-71. PubMed ID: 12181443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.
    Yuan ZQ; Sun M; Feldman RI; Wang G; Ma X; Jiang C; Coppola D; Nicosia SV; Cheng JQ
    Oncogene; 2000 May; 19(19):2324-30. PubMed ID: 10822383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells.
    Hemström TH; Sandström M; Zhivotovsky B
    Int J Cancer; 2006 Sep; 119(5):1028-38. PubMed ID: 16570272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.